← Back
$AQST All transactions

Aquestive Therapeutics, Inc.

A

$ Value

$0

Shares

75,000

Price

$0

Filed

Mar 11

Insider

Name

Korczynski Sherry

Title

Chief Commercial Officer

CIK

0002026090

Roles

Officer

Transaction Details

Transaction Date

2026-03-09

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

256,858

Footnotes

The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. | Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. | This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. | The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Filing Info

Accession No.

0001214659-26-003142

Form Type

4

Issuer CIK

0001398733

Korczynski Sherry's History

Date Ticker Type Value
2026-03-10 AQST $66K
2026-03-09 AQST A $0
2026-03-09 AQST A $182K
2025-08-14 AQST A $0
2025-06-09 AQST F $10K
2025-03-07 AQST A $0

Other Insiders at AQST (90d)

Insider Bought Sold Last
TOTH A ERNEST JR
Chief Financial Officer
$243K 2026-03-10
TOTH A ERNEST JR
SVP, Chief Financial Officer
2025-03-07
Boyd Peter E.
Chief People Officer
$124K 2026-03-10
Barber Daniel
President and CEO
$754K 2026-03-10
BRAENDER LORI J
Chief Legal Officer
$167K 2026-03-10
BRAENDER LORI J
Corporate Secretary
2025-03-07
Jung Cassie
Chief Operating Officer
$191K 2026-03-10
Korczynski Sherry
Chief Commercial Officer
$66K 2026-03-10
Cioffi Melina
SVP, Regulatory Affairs
$106K 2026-03-10
Davis Matthew W.
Chief Development Officer
2026-03-09
Greenhawt Matthew J.
Chief Medical Officer
2026-03-09